pepsico glp 1 CEO grilled about GLP-1s by a 13-year-old on Q1 conference call 🚨Report: PepsiCo says the growing

Understanding how GLP-1 coverage decisions and strategy gaps interact is essential before expanding into new formulations

For instance, in June 2024, UBC launched under-the-tongue insulin drops with rapid absorption, potentially replacing traditional injections for diabetes treatment

The Federal Circuit affirmed the district courts delisting order, finding the device patents were not properly listable because they did not claim a specific active ingredient and instead were only directed to components of the device

Further investigations are now needed to illustrate the modulatory mechanisms and effects of DPP-4i on BP

doi: 10.1124/jpet.106.100982

GLP-1 receptor agonists stimulate insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite through multiple physiological pathways